Profiel
Eva Gardyan-Eisenlohr currently works at Intendis GmbH, as Chief Legal Officer and Deutsche Biotech Innovativ AG, as Member-Supervisory Board.
Ms. Gardyan-Eisenlohr also formerly worked at Olympus Corp., as Global Chief Compliance Officer, Bayer Schering Pharma AG, as Head-Legal Department, and Bayer Pharma AG, as General Counsel & Group Data Protection Officer from 2016 to 2020.
Actieve functies van Eva Gardyan-Eisenlohr
| Bedrijven | Functie | Begin |
|---|---|---|
| DEUTSCHE BIOTECH INNOVATIV AG | Directeur/Bestuurslid | - |
Intendis GmbH
Intendis GmbH Pharmaceuticals: MajorHealth Technology Specializes in dermatological drugs | Algemeen Adviseur | - |
Eerdere bekende functies van Eva Gardyan-Eisenlohr
| Bedrijven | Functie | Einde |
|---|---|---|
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Algemeen Adviseur | 01-01-2020 |
Bayer Schering Pharma AG
Bayer Schering Pharma AG Medical SpecialtiesHealth Technology Manufactures pharmaceuticals and diagnostic substances | Algemeen Adviseur | - |
| OLYMPUS CORPORATION | Compliance Officer | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Bayer Schering Pharma AG
Bayer Schering Pharma AG Medical SpecialtiesHealth Technology Manufactures pharmaceuticals and diagnostic substances | Health Technology |
Intendis GmbH
Intendis GmbH Pharmaceuticals: MajorHealth Technology Specializes in dermatological drugs | Health Technology |
Olympus Corp.
Olympus Corp. Medical SpecialtiesHealth Technology Manufactures and sells precision machineries and instruments | Health Technology |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Deutsche Biotech Innovativ AG
Deutsche Biotech Innovativ AG Financial ConglomeratesFinance Invests in companies which are involved in innovative business concepts and technologies | Finance |
















